News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
85,651 Results
Type
Article (2056)
Company Profile (4)
Press Release (83591)
Section
Business (23332)
Career Advice (10)
Deals (4847)
Drug Development (9642)
FDA (2175)
Job Trends (1122)
News (41053)
Policy (3898)
Tag
Academia (111)
Accelerated approval (7)
Allergies (29)
Alliances (8518)
ALS (40)
Alzheimer's disease (256)
Antibody-drug conjugate (ADC) (108)
Approvals (2416)
Artificial intelligence (98)
Autoimmune disease (31)
Automation (10)
Bankruptcy (8)
Best Places to Work (1049)
Biosimilars (85)
Biotechnology (5)
Bladder cancer (84)
Brain cancer (12)
Breast cancer (224)
Cancer (1488)
Cardiovascular disease (91)
Career advice (10)
CAR-T (50)
Cell therapy (142)
Cervical cancer (12)
Clinical research (10105)
Collaboration (468)
Compensation (161)
Complete response letters (7)
COVID-19 (253)
CRISPR (17)
C-suite (128)
Cystic fibrosis (28)
Data (1851)
Depression (23)
Diabetes (83)
Diagnostics (883)
Digital health (8)
Drug discovery (61)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (64)
Earnings (10535)
Events (9881)
Executive appointments (149)
FDA (3219)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (5)
Funding (367)
Gene editing (33)
Generative AI (2)
Gene therapy (112)
GLP-1 (119)
Government (270)
Grass and pollen (3)
Guidances (136)
Healthcare (1289)
HIV (22)
Huntington's disease (8)
IgA nephropathy (32)
Immunology and inflammation (17)
Immuno-oncology (10)
Indications (32)
Infectious disease (309)
Inflammatory bowel disease (40)
Inflation Reduction Act (1)
Influenza (22)
Intellectual property (57)
IPO (1896)
Job creations (245)
Job search strategy (10)
JPM (3)
Kidney cancer (4)
Layoffs (6)
Legal (974)
Liver cancer (34)
Longevity (2)
Lung cancer (237)
Lymphoma (116)
Machine learning (3)
Manufacturing (156)
MASH (42)
Medical device (1423)
Medtech (1434)
Mergers & acquisitions (3242)
Metabolic disorders (194)
Multiple sclerosis (43)
NASH (5)
Neurodegenerative disease (78)
Neuropsychiatric disorders (12)
Neuroscience (559)
NextGen: Class of 2026 (255)
Non-profit (84)
Obesity (62)
Opinion (1)
Ovarian cancer (57)
Pain (32)
Pancreatic cancer (40)
Parkinson's disease (88)
Partnered (3)
Patents (104)
Patient recruitment (126)
Peanut (6)
People (5537)
Pharmaceutical (4)
Pharmacy benefit managers (5)
Phase 1 (2671)
Phase 2 (4147)
Phase 3 (4008)
Pipeline (1532)
Policy (1)
Postmarket research (339)
Preclinical (908)
Press Release (2)
Prostate cancer (76)
Psychedelics (1)
Radiopharmaceuticals (29)
Rare diseases (187)
Real estate (616)
Regulatory (3732)
Reports (7)
Research institute (123)
Rett syndrome (16)
RNA editing (3)
RSV (22)
Schizophrenia (37)
Series A (56)
Series B (64)
Service/supplier (1)
Sickle cell disease (27)
Spinal muscular atrophy (14)
Sponsored (5)
Startups (430)
Stomach cancer (1)
Supply chain (22)
Vaccines (103)
Venture capital (8)
Weight loss (15)
Women's health (15)
Date
Last 7 days (139)
Last 30 days (508)
Last 365 days (7733)
2026 (725)
2025 (7779)
2024 (5538)
2023 (4545)
2022 (7805)
2021 (7127)
2020 (6534)
2019 (4285)
2018 (3317)
2017 (3897)
2016 (3442)
2015 (4330)
2014 (3235)
2013 (2717)
2012 (2876)
2011 (3019)
2010 (2781)
Location
Africa (92)
Alabama (6)
Arizona (14)
Arkansas (1)
Asia (22446)
Australia (2542)
California (2549)
Canada (710)
China (463)
Colorado (76)
Connecticut (116)
Delaware (145)
Europe (15826)
Florida (190)
Georgia (54)
Hawaii (2)
Idaho (3)
Illinois (191)
India (37)
Indiana (37)
Iowa (5)
Japan (302)
Kansas (8)
Kentucky (3)
Louisiana (3)
Maine (6)
Maryland (231)
Massachusetts (1967)
Michigan (41)
Minnesota (110)
Missouri (33)
Nebraska (3)
Nevada (39)
New Hampshire (5)
New Jersey (852)
New Mexico (1)
New York (611)
North Carolina (225)
North Dakota (2)
Northern California (1142)
Ohio (60)
Oregon (5)
Pennsylvania (311)
Puerto Rico (1)
Rhode Island (8)
South America (116)
South Carolina (3)
Southern California (1018)
Tennessee (25)
Texas (396)
United States (8478)
Utah (38)
Virginia (104)
Washington D.C. (9)
Washington State (193)
Wisconsin (43)
85,651 Results for "f2g ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim
June 19, 2025
·
9 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
January 29, 2026
·
8 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
·
3 min read
Press Releases
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment
December 3, 2025
·
4 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
October 14, 2025
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Appointment of CFO
December 1, 2025
·
3 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)
December 16, 2025
·
3 min read
Press Releases
Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM
February 5, 2026
·
4 min read
1 of 8,566
Next
